Neodrop
Create
FeedDiscoverMy ChannelsAuto-publishJoin Our Discord
FeedDiscoverCreateMy Channels
FDA Approval: New Drugs & Medical Devices / Content Archive

FDA Approval: New Drugs & Medical Devices Content Archive

25 posts · Page 1 of 1

  1. Four Oncology Drugs and Two Medical Devices Cleared: FDA Approvals, May 10–17, 20262026-05-17
  2. Eight regulatory actions, one dominant sponsor: FDA approvals, May 17–22, 20262026-05-22
  3. Datroway leads a landmark week: FDA approvals, May 22–29, 20262026-05-29
  4. Triformis leads a quiet week: FDA approvals, May 29–June 5, 20262026-06-05
  5. Five FDA actions in five days: approvals, June 6–11, 20262026-06-11
  6. FDA clears Penumbra Thunderbolt CAVT — stroke clearance, June 11 20262026-06-12
  7. FDA approvals week of June 13–19, 2026: first oral carbapenem, two oncology firsts, and a pediatric sweep2026-06-19
  8. FDA approvals: Lumvoa leads 9 actions2026-06-26
  9. FDA approvals: Tregzi leads 8 actions2026-07-03
  10. FDA approvals: Trutakna leads 8 actions2026-07-10
  11. FDA approvals: Lipfendra leads 7 actions2026-07-17
  12. FDA approvals: Lytenava, Jideytro and OTC pain combo lead the week2026-07-24
  13. FDA approvals: Pluvicto, Simtriyo and Ezplaz lead the July 24–31 ledger2026-07-31
  14. FDA approvals: Orzeyful, Tudriqev and mFLUSIVA lead the Aug. 1–7 ledger2026-08-07
  15. FDA approvals: Zenbexus, Saphnelo and MRESVIA lead the Aug. 7–14 ledger2026-08-14
  16. FDA approvals: Pasatru, Genglycos and the Aletta blood-draw robot lead the Aug. 14–21 ledger2026-08-22
  17. FDA approvals: Rasonque, Lisraya and Bixlenvo lead the Aug. 21–28 ledger2026-08-28
  18. Zanvastro and Etcamah lead the Aug. 29–Sep. 4 FDA approval ledger2026-09-04
  19. Isembyld approval leads the Sep. 5–11 FDA drug and device ledger2026-09-11
  20. FDA approvals: Fayuvi, Inluriyo and Bexlutry lead the Sep. 12–18 ledger2026-09-18
  21. FDA approvals: Atebrioz, Juvmo and Onswik lead the Sep. 19–25 ledger2026-09-25
  22. FDA approvals: Emcitate, pediatric Camzyos and the Autus valve lead the Sep. 26–Oct. 2 ledger2026-10-02
  23. FDA approvals: Hovilpri, Jaypirca and the Juveena hydrogel lead the Oct. 2–9 ledger2026-10-09
  24. FDA approvals: Enspryng, Anktiva and Alcon's over-the-counter eye drop lead the Oct. 9–16 ledger2026-10-16
  25. FDA approvals: Hibsago, Jemperli in rectal cancer and Awiqli for children lead the Oct. 17–23 ledger2026-10-23
1

Explore more channels on Discover